• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症对接受手术治疗的非小细胞肺癌患者的生存有影响吗?

Does sarcopenia have any impact on survival of patients with surgically treated non-small-cell lung cancer?

作者信息

Deng Han-Yu, Zha Panpan, Hou Liang, Huang Kai-Li

机构信息

Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Interact Cardiovasc Thorac Surg. 2019 Jul 1;29(1):144-147. doi: 10.1093/icvts/ivz039.

DOI:10.1093/icvts/ivz039
PMID:30843065
Abstract

A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was 'Does sarcopenia have any impact on survival of patients with surgically treated non-small-cell lung cancer (NSCLC)?'. Altogether, 342 papers were found using the reported search, of which 9 cohort studies represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Eight of the studies measured skeletal muscle or total psoas cross-sectional area at the level of the first or third lumbar vertebra normalized for the square of height for defining sarcopenia, while 1 study used absolute measurement of total psoas cross-sectional area. Seven of 8 studies looking at overall survival found that patients with sarcopenia had significantly worse overall survival than those without after surgical resection of NSCLC, while 1 failed to show a difference. Five studies reported disease-free survival, with 3 studies showing no difference and 2 showing that patients with sarcopenia had a significantly worse disease-free survival than those without. One study found that sarcopenia was a predictor of early recurrence in NSCLC patient after surgical resection. Therefore, we conclude that sarcopenia could serve as a predictor of poor prognosis of patients with surgically treated NSCLC.

摘要

根据结构化方案撰写了一篇胸外科最佳证据主题文章。所探讨的问题是“肌肉减少症对接受手术治疗的非小细胞肺癌(NSCLC)患者的生存有何影响?”。通过报告的检索共找到342篇论文,其中9项队列研究代表了回答该临床问题的最佳证据。这些论文的作者、期刊、发表日期和国家、所研究的患者组、研究类型、相关结局和结果均列于表格中。8项研究中有7项通过测量第一或第三腰椎水平的骨骼肌或总腰大肌横截面积并按身高平方进行标准化来定义肌肉减少症,而1项研究使用了总腰大肌横截面积的绝对测量值。在8项关注总生存的研究中,有7项发现肌肉减少症患者在接受NSCLC手术切除后的总生存明显差于无肌肉减少症的患者,而1项未显示出差异。5项研究报告了无病生存情况,其中3项研究显示无差异,2项研究表明肌肉减少症患者的无病生存明显差于无肌肉减少症的患者。1项研究发现肌肉减少症是NSCLC患者手术切除后早期复发的预测因素。因此,我们得出结论,肌肉减少症可作为接受手术治疗的NSCLC患者预后不良的预测指标。

相似文献

1
Does sarcopenia have any impact on survival of patients with surgically treated non-small-cell lung cancer?肌肉减少症对接受手术治疗的非小细胞肺癌患者的生存有影响吗?
Interact Cardiovasc Thorac Surg. 2019 Jul 1;29(1):144-147. doi: 10.1093/icvts/ivz039.
2
In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy an appropriate alternative to video-assisted thoracoscopic lobectomy?在可切除的非小细胞肺癌患者中,电视辅助胸腔镜肺段切除术是否是电视辅助胸腔镜肺叶切除术的合适替代方案?
Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):826-831. doi: 10.1093/icvts/ivw202. Epub 2016 Jul 11.
3
In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection?在可切除的非小细胞肺癌患者中,就发病率和切除等效性而言,电视辅助胸腔镜肺段切除术是否是开胸肺段切除术的合适替代方案?
Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):107-10. doi: 10.1093/icvts/ivu080. Epub 2014 Apr 10.
4
Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?对于T1N0M0期非小细胞肺癌患者,肺叶切除术在生存率和复发率方面是否比局限性肺切除术更好?
Interact Cardiovasc Thorac Surg. 2009 Mar;8(3):364-72. doi: 10.1510/icvts.2008.178947. Epub 2008 Jul 18.
5
Does the sequence of pulmonary vasculature ligation have any oncological impact during an anatomical lung resection for non-small-cell lung cancer?在非小细胞肺癌的解剖性肺切除术中,肺血管结扎顺序是否会对肿瘤学产生任何影响?
Interact Cardiovasc Thorac Surg. 2015 Feb;20(2):260-4. doi: 10.1093/icvts/ivu361. Epub 2014 Oct 29.
6
Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer.术前计算机断层扫描确定的肌肉减少症与非小细胞肺癌手术后的术后结果
Scand J Surg. 2018 Sep;107(3):244-251. doi: 10.1177/1457496917748221. Epub 2017 Dec 28.
7
Is systematic lymph node dissection mandatory or is sampling adequate in patients with stage I non-small-cell lung cancer?对于Ⅰ期非小细胞肺癌患者,系统性淋巴结清扫是必需的吗?还是采样就足够了?
Interact Cardiovasc Thorac Surg. 2019 Apr 1;28(4):550-554. doi: 10.1093/icvts/ivy309.
8
Is a sleeve lobectomy significantly better than a pneumonectomy?袖状肺叶切除术明显优于全肺切除术吗?
Interact Cardiovasc Thorac Surg. 2010 Nov;11(5):660-6. doi: 10.1510/icvts.2010.245506. Epub 2010 Aug 19.
9
Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.肌肉减少症预示着老年肺癌患者术后预后不良。
Gen Thorac Cardiovasc Surg. 2019 Nov;67(11):949-954. doi: 10.1007/s11748-019-01125-3. Epub 2019 Apr 10.
10
Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.术后骨骼肌减少对非小细胞肺癌的预后影响。
Ann Thorac Surg. 2020 Mar;109(3):914-920. doi: 10.1016/j.athoracsur.2019.09.035. Epub 2019 Oct 23.

引用本文的文献

1
The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance.肌肉减少症对非小细胞肺癌中PD-1抑制剂疗效的影响及克服耐药性的潜在策略。
Front Pharmacol. 2024 Jul 19;15:1377666. doi: 10.3389/fphar.2024.1377666. eCollection 2024.
2
Comparison of frailty indexes as predictors of clinical outcomes after major thoracic surgery.作为主要胸外科手术后临床结局预测指标的衰弱指数比较
J Thorac Dis. 2024 May 31;16(5):3192-3203. doi: 10.21037/jtd-23-963. Epub 2024 May 29.
3
Computed tomography measured epicardial adipose tissue and psoas muscle attenuation: new biomarkers to predict major adverse cardiac events and mortality in patients with heart disease and critically ill patients. Part II: Psoas muscle area and density.
计算机断层扫描测量心外膜脂肪组织和腰大肌衰减:预测心脏病和危重症患者主要不良心脏事件和死亡率的新生物标志物。第二部分:腰大肌面积和密度。
Anaesthesiol Intensive Ther. 2023;55(4):243-261. doi: 10.5114/ait.2023.132460.
4
The Role of Neurotrophin-4/Forkhead Box L1 in the Development of Nonsmall-Cell Lung Cancer.神经生长因子 4/叉头框蛋白 L1 在非小细胞肺癌发展中的作用。
Contrast Media Mol Imaging. 2022 Aug 9;2022:9078012. doi: 10.1155/2022/9078012. eCollection 2022.
5
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.骨骼肌测量与非小细胞肺癌患者化疗诱导毒性的关系。
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1554-1564. doi: 10.1002/jcsm.12967. Epub 2022 Mar 18.
6
It is time to consider incorporating sarcopenia assessment in the surgical management of non-small-cell lung cancer.是时候考虑将肌肉减少症评估纳入非小细胞肺癌的外科治疗中了。
Gen Thorac Cardiovasc Surg. 2019 Jul;67(7):653-654. doi: 10.1007/s11748-019-01144-0. Epub 2019 May 27.